We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Aural ECG Device Diagnoses Heart Sounds

By HospiMedica International staff writers
Posted on 21 Aug 2017
A non-invasive, radiation-free acoustic electrocardiogram (ECG) device helps physicians detects both physiological and pathological heart murmurs.

The AUM Cardiovascular (Northfield, MN, USA) CADence device is a portable tool to diagnose valvular heart disease, congestive heart failure (CHF), and obstructive coronary artery disease; it can also be used to assess and track native, transcatheter, bioprosthetic, and mechanical heart valve function remotely. More...
The device requires minimal training for operation and records audio turbulence signals from within the coronary arteries at four thorax wall locations. The turbulence is identified using a proprietary algorithm built into the device.

Data is then uploaded via Bluetooth to a tablet and analyzed by proprietary analytics engine. The results are available on the tablet itself and are also sent to a centralized email address for immediate report generation, long-term assessment, and record keeping, either in the electronic health record (HER) or printed for the patient chart. Audio data files can also be listened to directly on the tablet using earbuds. Testing can be conducted in less than 20 minutes, with diagnostic results available in minutes, thus avoiding long waits or lengthy testing protocols and possible follow-up appointments.

“If a patient does not have significant obstructive coronary artery disease, the CADence System will be able to confirm this approximately 9 out of 10 times,” said Marie Johnson, CEO of AUM Cardiovascular. “This efficient, noninvasive and reusable device has a lower safety risk profile than other diagnostic screening tests such as such as nuclear stress testing, computed tomography, and angiography.”

“The CADence system has the potential to dramatically enhance our ability to rule-out significant coronary artery disease and efficiently triage patients needing additional testing,” said interventional cardiologist Jay Thomas, MD, of Harbor-UCLA Medical Center (Los Angeles, CA, USA). “It is a rapid, cost-effective, radiation-free way to evaluate selected patients with chest pain. The need for something like CADence is quite obvious, considering how we have managed chest pain testing for the last twenty years.”

Related Links:
AUM Cardiovascular


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.